BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30213543)

  • 1. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative C-reactive protein level adjusted for comorbidities and lifestyle factors predicts overall mortality in localized renal cell carcinoma.
    Michigan A; Johnson TV; Master VA
    Mol Diagn Ther; 2011 Aug; 15(4):229-34. PubMed ID: 21756006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma.
    Dalpiaz O; Luef T; Seles M; Stotz M; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    Br J Cancer; 2017 Jan; 116(1):85-90. PubMed ID: 27907929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival.
    Teishima J; Ohara S; Shinmei S; Inoue S; Hayashi T; Mochizuki H; Mita K; Shigeta M; Matsubara A
    Urol Oncol; 2018 Jul; 36(7):339.e9-339.e15. PubMed ID: 29773493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.
    Steffens S; Köhler A; Rudolph R; Eggers H; Seidel C; Janssen M; Wegener G; Schrader M; Kuczyk MA; Schrader AJ
    BMC Cancer; 2012 Sep; 12():399. PubMed ID: 22958305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
    Omae K; Kondo T; Tanabe K
    Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative C-Reactive Protein Values as a Potential Component in Outcome Prediction Models of Metastasized Renal Cell Carcinoma Patients Receiving Cytoreductive Nephrectomy.
    Kalogirou C; Mulfinger P; Sokolakis I; Krebs M; Kübler H; Riedmiller H; Vergho D
    Urol Int; 2017; 99(3):297-307. PubMed ID: 28624829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab.
    Suzuki K; Terakawa T; Furukawa J; Harada K; Hinata N; Nakano Y; Fujisawa M
    Int J Clin Oncol; 2020 Jan; 25(1):135-144. PubMed ID: 31512006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma.
    Gao J; Agizamhan S; Zhao X; Jiang B; Qin H; Chen M; Guo H
    Future Oncol; 2019 May; 15(13):1459-1468. PubMed ID: 30977386
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
    Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X
    Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
    Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma.
    Hamidi N; Gökçe MI; Süer E; Baltaci S
    Clin Nephrol; 2015 Apr; 83(4):225-30. PubMed ID: 25707457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.
    Kang HW; Seo SP; Kim WT; Yun SJ; Lee SC; Kim WJ; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Byun SS; Kim YJ;
    Int J Clin Oncol; 2018 Feb; 23(1):142-150. PubMed ID: 28791497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.
    Lamb GW; McArdle PA; Ramsey S; McNichol AM; Edwards J; Aitchison M; McMillan DC
    BJU Int; 2008 Sep; 102(6):756-61. PubMed ID: 18384626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
    Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
    World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
    J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.